Table 3.

Ischaemic and bleeding events before and after detection of new, non-benign neoplasm events

Event, n (%)		Timing of eventa
	Total (n = 170)	Before new, non-benign neoplasm	After new, non-benign neoplasm
Cardiovascular death, MI, or stroke	31 (18.2)	17 (54.8)	14 (45.2)
All-cause death	48 (28.2)	0	48 (100.0)
GUSTO severe/life-threatening, or moderate bleeding	19 (11.2)	13 (68.4)	6 (31.6)
TIMI major or minor bleeding	20 (11.8)	16 (80.0)	4 (20.0)

Event rates reported as the percentage of treated subjects.

GUSTO, Global Use of Strategies to Open Occluded Arteries; MI, myocardial infarction; TIMI, thrombolysis in myocardial infarction.

^aPercentages of total events shown in parentheses for each column.